Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping and the Future of Transfusion in Sickle Cell Disease.

Hematology/oncology clinics of North America - 1 Dec 2022

Karafin Matthew S, Howard Jo

Abstract excerpt

Patients with sickle cell disease (SCD) have a high rate of red cell alloimmunization, which increases morbidity and mortality. Reasons for this susceptibility are multifactorial, but differences in antigen frequency between donors and recipients are one of the modifiable risk factors. Here, we evaluate the benefits of red cell molecular antigen-typing for both patients with SCD and their donors and describe how...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Blood Transfusion
Share to Erythrocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Isoantibodies

Source

Identifiers

PMID: 36400543
DOI: 10.1016/j.hoc.2022.07.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping and the Future of Transfusion in Sickle Cell Disease.PMID 36400543Read ↗

Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.Semantic proximity Read ↗

Application of genomics for transfusion therapy in sickle cell anemia.Semantic proximity Read ↗

Red Blood Cell Alloimmunization in Sickle Cell Disease: Listen to Your AncestorsSemantic proximity Read ↗

Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.Semantic proximity Read ↗

Identification of genetic biomarkers for alloimmunization in sickle cell disease.Semantic proximity Read ↗

Molecular testing for transfusion medicine.Semantic proximity Read ↗

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.Semantic proximity Read ↗

Mass-scale donor red cell genotyping using real-time array technology.Semantic proximity Read ↗

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.Semantic proximity Read ↗

Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice.Semantic proximity Read ↗

Using red blood cell genomics in transfusion medicine.Semantic proximity Read ↗

Changing practice: red blood cell typing by molecular methods for patients with sickle cell diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.